California
|
|
94-2424084
|
(State
or other jurisdiction of
|
|
(I.R.S.
Employer Identification No.)
|
incorporation
or organization)
|
|
|
|
|
|
400
Kato Terrace
|
|
|
Fremont, CA
|
|
94539
|
(Address of principal
|
|
(Zip
Code)
|
executive offices)
|
|
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
Non-accelerated
filer
|
☒
|
Smaller reporting company
|
☒
|
Emerging
growth company
|
☐
|
|
|
PART I. FINANCIAL INFORMATION
|
|
|
|
ITEM 1. Financial Statements (Unaudited)
|
|
|
|
Condensed Consolidated Balance Sheets at
August 31, 2018 and May 31, 2018
|
4
|
|
|
Condensed
Consolidated Statements of Operations for the Three Months Ended
August 31, 2018 and 2017
|
5
|
|
|
Condensed Consolidated Statements of Comprehensive
(Loss) Income for the Three Months Ended August 31, 2018 and
2017
|
6
|
|
|
Condensed Consolidated Statements of Cash Flows
for the Three Months Ended August 31, 2018 and
2017
|
7
|
|
|
Notes
to Condensed Consolidated Financial Statements
|
8
|
|
|
ITEM 2. Management's Discussion and Analysis of Financial Condition
and Results of Operations
|
21
|
|
|
ITEM 3. Quantitative and Qualitative Disclosures About Market
Risks
|
25
|
|
|
ITEM 4. Controls and Procedures
|
26
|
|
|
|
|
PART II. OTHER INFORMATION
|
|
|
|
ITEM 1. Legal Proceedings
|
26
|
|
|
ITEM 1A. Risk Factors
|
26
|
|
|
ITEM 2. Unregistered Sales of Equity Securities and Use of
Proceeds
|
27
|
|
|
ITEM 3. Defaults Upon Senior Securities
|
27
|
|
|
ITEM 4. Mine Safety Disclosures
|
27
|
|
|
ITEM 5. Other Information
|
27
|
|
|
ITEM 6. Exhibits
|
27
|
|
|
SIGNATURES
|
28
|
|
August 31,
|
May 31,
|
|
2018
|
2018
|
|
(1)
|
|
ASSETS
|
|
|
Current
assets:
|
|
|
Cash
and cash equivalents
|
$15,864
|
$16,848
|
Accounts
receivable, net
|
2,272
|
2,856
|
Inventories
|
9,585
|
9,049
|
Prepaid
expenses and other current assets
|
727
|
703
|
|
|
|
Total
current assets
|
28,448
|
29,456
|
|
|
|
Property
and equipment, net
|
1,174
|
1,203
|
Other
assets
|
266
|
296
|
|
|
|
Total
assets
|
$29,888
|
$30,955
|
|
|
|
LIABILITIES
AND SHAREHOLDERS' EQUITY
|
|
|
Current
liabilities:
|
|
|
Accounts
payable
|
$1,317
|
$1,762
|
Accrued
expenses
|
1,498
|
1,646
|
Customer
deposits and deferred revenue, short-term
|
2,339
|
1,630
|
Current
portion of long-term debt
|
6,110
|
6,110
|
|
|
|
Total
current liabilities
|
11,264
|
11,148
|
|
|
|
Deferred
rent
|
145
|
63
|
Deferred
revenue, long-term
|
359
|
459
|
|
|
|
Total
liabilities
|
11,768
|
11,670
|
|
|
|
Aehr
Test Systems shareholders' equity:
|
|
|
Common
stock, $0.01 par value: Authorized:
75,000;
Issued and outstanding: 22,245 shares and 22,143
shares at August 31, 2018 and May 31, 2018,
respectively
|
222
|
221
|
Additional
paid-in capital
|
83,405
|
83,041
|
Accumulated
other comprehensive income
|
2,276
|
2,292
|
Accumulated
deficit
|
(67,764)
|
(66,249)
|
|
|
|
Total
Aehr Test Systems shareholders' equity
|
18,139
|
19,305
|
Noncontrolling
interest
|
(19)
|
(20)
|
|
|
|
Total
shareholders' equity
|
18,120
|
19,285
|
|
|
|
Total
liabilities and shareholders' equity
|
$29,888
|
$30,955
|
|
Three Months
Ended
|
|
|
August
31,
|
|
|
2018
|
2017
|
|
|
|
Net
sales
|
$4,740
|
$6,970
|
Cost of
sales
|
3,187
|
4,052
|
Gross
profit
|
1,553
|
2,918
|
|
|
|
Operating
expenses:
|
|
|
Selling,
general and administrative
|
1,879
|
1,791
|
Research and
development
|
1,116
|
955
|
Total
operating expenses
|
2,995
|
2,746
|
|
|
|
(Loss)
income from operations
|
(1,442)
|
172
|
|
|
|
Interest expense,
net
|
(78)
|
(107)
|
Other income
(expense), net
|
9
|
(60)
|
|
|
|
(Loss)
income before income tax (expense)
benefit
|
(1,511)
|
5
|
|
|
|
Income tax
(expense) benefit
|
(4)
|
5
|
|
|
|
Net (loss)
income
|
(1,515)
|
10
|
Less:
Net income attributable to the noncontrolling
interest
|
--
|
--
|
|
|
|
Net (loss) income
attributable to Aehr
Test Systems
common shareholders
|
$(1,515)
|
$10
|
|
|
|
|
|
|
Net (loss) income
per share
|
|
|
Basic
|
$(0.07)
|
$0.00
|
Diluted
|
$(0.07)
|
$0.00
|
|
|
|
Shares
used in per share calculations:
|
||
Basic
|
22,190
|
21,417
|
Diluted
|
22,190
|
22,991
|
|
Three Months
Ended
|
|
|
August
31,
|
|
|
2018
|
2017
|
|
|
|
Net (loss)
income
|
$(1,515)
|
$10
|
Other comprehensive
(loss) income, net of tax:
Net
change in cumulative translation adjustments
|
(15)
|
59
|
|
|
|
Total comprehensive
(loss) income
|
(1,530)
|
69
|
Less: Comprehensive
income attributable to the
noncontrolling interest
|
1
|
--
|
|
|
|
Comprehensive
(loss) income, attributable
to Aehr Test Systems common
shareholders
|
$(1,531)
|
$69
|
|
Three Months
Ended
|
|
|
August
31,
|
|
|
2018
|
2017
|
Cash
flows from operating activities:
|
|
|
Net
(loss) income
|
$(1,515)
|
$10
|
Adjustments
to reconcile net (loss) income to net cash used in operating
activities:
|
|
|
Stock-based
compensation expense
|
256
|
216
|
Provision
for doubtful accounts
|
--
|
31
|
Depreciation
and amortization
|
111
|
89
|
Changes
in operating assets and liabilities:
|
|
|
Accounts
receivable
|
563
|
(1,260)
|
Inventories
|
(536)
|
(2,044)
|
Prepaid
expenses and other current assets
|
4
|
(1,089)
|
Accounts
payable
|
(398)
|
651
|
Accrued
expenses
|
(151)
|
(21)
|
Customer
deposits and deferred revenue
|
609
|
(440)
|
Deferred
rent
|
82
|
--
|
Income
taxes payable
|
4
|
(20)
|
Net
cash used in operating activities
|
(971)
|
(3,877)
|
|
|
|
Cash
flows from investing activities:
|
|
|
Purchases
of property and equipment
|
(84)
|
(184)
|
Net
cash used in investing activities
|
(84)
|
(184)
|
|
|
|
Cash
flows from financing activities:
|
|
|
Proceeds
from issuance of common stock under employee plans, net of
taxes paid related to
share settlement of equity awards
|
109
|
234
|
Net
cash provided by financing activities
|
109
|
234
|
|
|
|
Effect
of exchange rates on cash and cash equivalents
|
(38)
|
17
|
|
|
|
Net
decrease in cash and cash
equivalents
|
(984)
|
(3,810)
|
|
|
|
Cash
and cash equivalents, beginning of period
|
16,848
|
17,803
|
|
|
|
Cash
and cash equivalents, end of period
|
$15,864
|
$13,993
|
|
|
|
Supplemental
disclosure of non-cash flow information:
|
|
|
Transfers
of property and equipment to inventories
|
$--
|
$372
|
|
Three Months
Ended
|
|
|
August
31,
|
|
|
2018
|
2017
|
|
|
|
Numerator:
Net (loss) income
|
$(1,515)
|
$10
|
|
|
|
Denominator
for basic net (loss) income per share:
|
|
|
Weighted
average shares outstanding
|
22,190
|
21,417
|
|
|
|
Shares used in basic net (loss) income per share
calculation
|
22,190
|
21,417
|
Effect
of dilutive securities
|
--
|
1,574
|
|
|
|
Denominator
for diluted net (loss) income per share
|
22,190
|
22,991
|
|
|
|
Basic
net (loss) income per share
|
$(0.07)
|
$0.00
|
Diluted
net (loss) income per share
|
$(0.07)
|
$0.00
|
|
Cost
|
Gross Unrealized Loss
|
Estimated Fair Value
|
|
|
|
|
Cash
|
$2,587
|
$--
|
$2,587
|
Cash
equivalents:
|
|
|
|
Money
market funds
|
13,277
|
--
|
13,277
|
U.S.
Treasury securities
|
--
|
--
|
--
|
Total
Cash equivalents
|
13,277
|
--
|
13,277
|
Total
Cash and Cash equivalents
|
$15,864
|
$--
|
$15,864
|
Long-term
investments:
|
|
|
|
Certificate
of deposit
|
$80
|
$--
|
$80
|
Total
Cash, Cash equivalents and Investments
|
$15,944
|
$--
|
$15,944
|
|
Cost
|
Gross Unrealized Loss
|
Estimated Fair Value
|
|
|
|
|
Cash
|
$3,132
|
$--
|
$3,132
|
Cash
equivalents:
|
|
|
|
Money
market funds
|
7,733
|
--
|
7,733
|
U.S.
Treasury securities
|
5,983
|
--
|
5,983
|
Total
Cash equivalents
|
13,716
|
--
|
13,716
|
Total
Cash and Cash equivalents
|
$16,848
|
$--
|
$16,848
|
Long-term
investments:
|
|
|
|
Certificate
of deposit
|
$80
|
$--
|
$80
|
Total
Cash, Cash equivalents and Investments
|
$16,928
|
$--
|
$16,928
|
|
Balance as of August 31, 2018
|
Level 1
|
Level 2
|
Level 3
|
Money
market funds
|
$13,277
|
$13,277
|
$--
|
$--
|
Certificate
of deposit
|
80
|
--
|
80
|
--
|
Assets
|
$13,357
|
$13,277
|
$80
|
$--
|
|
Balance as of May 31, 2018
|
Level 1
|
Level 2
|
Level 3
|
Money
market funds
|
$7,733
|
$7,733
|
$--
|
$--
|
U.S.
Treasury securities
|
5,983
|
5,983
|
--
|
--
|
Certificate
of deposit
|
80
|
--
|
80
|
--
|
Assets
|
$13,796
|
$13,716
|
$80
|
$--
|
|
August 31,
|
May 31,
|
|
2018
|
2018
|
Raw
materials and sub-assemblies
|
$6,103
|
$5,747
|
Work
in process
|
3,248
|
3,068
|
Finished
goods
|
234
|
234
|
|
$9,585
|
$9,049
|
|
Three Months Ended
|
|
|
August 31,
|
|
|
2018
|
2017
|
|
|
|
Balance
at the beginning of the period
|
$135
|
$113
|
|
|
|
Accruals for warranties issued during the
period
|
75
|
94
|
Consumption
of reserves
|
(50)
|
(88)
|
|
|
|
Balance
at the end of the period
|
$160
|
$119
|
|
August 31,
|
May 31,
|
|
2018
|
2018
|
Customer
deposits
|
$2,014
|
$1,340
|
Deferred
revenue
|
325
|
290
|
|
$2,339
|
$1,630
|
|
Cumulative Translation Adjustments
|
Unrealized Loss on Investments, Net
|
Total
|
|
|
|
|
Balance
at May 31, 2018
|
$2,292
|
$--
|
$2,292
|
Other
comprehensive (loss) income before reclassifications
|
(16)
|
--
|
(16)
|
Amounts
reclassified out of AOCI
|
--
|
--
|
--
|
Other
comprehensive (loss) income, net of tax
|
(16)
|
--
|
(16)
|
Balance
at August 31, 2018
|
$2,276
|
$--
|
$2,276
|
|
Three Months
Ended
|
|
|
August
31,
|
|
|
2018
|
2017
|
Stock-based
compensation in the form of employee stock options, RSUs and ESPP
purchase rights, included in:
|
|
|
Cost
of sales
|
$36
|
$22
|
Selling,
general and administrative
|
148
|
150
|
Research
and development
|
72
|
44
|
Net
effect on net (loss) income
|
$256
|
$216
|
|
Three Months
Ended
|
|
|
August
31,
|
|
|
2018
|
2017
|
|
|
|
Expected
term (in years)
|
5
|
4
|
Volatility
|
0.74
|
0.78
|
Risk-free
interest rate
|
2.75%
|
1.75%
|
Weighted
average grant date fair value
|
$1.48
|
$2.27
|
|
Available
|
|
Shares
|
Balance,
May 31, 2018
|
1,812
|
|
|
Options
granted
|
(441)
|
RSUs
granted
|
--
|
Shares
cancelled
|
13
|
Shares
expired
|
(11)
|
|
|
Balance,
August 31, 2018
|
1,373
|
|
Outstanding Options
|
||
|
|
Weighted
|
|
|
Number
|
Average
|
Aggregate
|
|
of
|
Exercise
|
Intrinsic
|
|
Shares
|
Price
|
Value
|
Balances,
May 31, 2018
|
2,859
|
$2.04
|
$1,987
|
|
|
|
|
Options
granted
|
441
|
$2.40
|
|
Options
cancelled
|
(13)
|
$1.64
|
|
Options
exercised
|
(98)
|
$1.12
|
|
|
|
|
|
Balances,
August 31, 2018
|
3,189
|
$2.12
|
$1,757
|
|
|
|
|
Options fully vested and expected to vest at August 31,
2018
|
3,156
|
$2.12
|
$1,746
|
|
Options
Outstanding
|
Options
Exercisable
|
|||||
|
at August 31,
2018
|
at August 31,
2018
|
|||||
Range of
Exercise
Prices
|
Number
Outstanding Shares
|
Weighted Average
Remaining Contractual Life (Years)
|
Weighted Average
Exercise Price
|
Number
Exercisable Shares
|
Weighted Average
Remaining Contractual Life (Years)
|
Weighted Average
Exercise Price
|
Aggregate
Intrinsic Value
|
$0.59-$0.97
|
259
|
0.51
|
$0.67
|
259
|
0.51
|
$0.67
|
|
$1.09-$1.36
|
507
|
1.46
|
$1.28
|
506
|
1.46
|
$1.28
|
|
$1.68-$2.06
|
466
|
4.04
|
$1.74
|
318
|
3.64
|
$1.77
|
|
$2.10-$2.81
|
1,695
|
4.34
|
$2.44
|
1,130
|
3.26
|
$2.47
|
|
$3.46-$3.93
|
262
|
5.91
|
$3.86
|
94
|
5.96
|
$3.76
|
|
$0.59-$3.93
|
3,189
|
3.66
|
$2.12
|
2,307
|
2.72
|
$1.96
|
$1,541
|
|
United
|
|
|
|
|
States
|
Asia
|
Europe
|
Total
|
Three
months ended August 31, 2018:
|
|
|
|
|
Net
sales
|
$2,695
|
$1,734
|
$311
|
$4,740
|
Property
and equipment, net
|
1,130
|
39
|
5
|
1,174
|
|
|
|
|
|
Three
months ended August 31, 2017:
|
|
|
|
|
Net
sales
|
$1,290
|
$5,660
|
$20
|
$6,970
|
Property
and equipment, net
|
1,089
|
39
|
12
|
1,140
|
|
Three Months Ended
|
|
|
August 31,
|
|
|
2018
|
2017
|
Type
of good / service:
|
|
|
Systems
|
$1,806
|
$3,476
|
Contactors
|
1,153
|
2,677
|
Services
|
1,781
|
817
|
|
$4,740
|
$6,970
|
|
|
|
Timing
of revenue recognition:
|
|
|
Products
and services transferred at a point
in time
|
$4,118
|
$6,500
|
Services
transferred over time
|
622
|
470
|
|
$4,740
|
$6,970
|
|
Three Months Ended
|
|
|
August 31,
|
|
|
2018
|
2017
|
|
|
|
Net
sales
|
100.0%
|
100.0%
|
Cost
of sales
|
67.2
|
58.1
|
Gross
profit
|
32.8
|
41.9
|
|
|
|
Operating
expenses:
|
|
|
Selling,
general and administrative
|
39.6
|
25.7
|
Research
and development
|
23.6
|
13.7
|
|
|
|
Total
operating expenses
|
63.2
|
39.4
|
|
|
|
(Loss)
income from operations
|
(30.4)
|
2.5
|
|
|
|
Interest
expense, net
|
(1.7)
|
(1.5)
|
Other
income (expense), net
|
0.2
|
(0.9)
|
|
|
|
(Loss)
income before income tax (expense)
benefit
|
(31.9)
|
0.1
|
|
|
|
Income
tax (expense) benefit
|
(0.1)
|
--
|
|
|
|
Net
(loss) income
|
(32.0)
|
0.1
|
Less:
Net income attributable to
the noncontrolling interest
|
--
|
--
|
Net
(loss) income attributable to Aehr Test
Systems common shareholders
|
(32.0)%
|
0.1%
|
Exhibit No.
|
|
Description
|
|
|
|
|
Certification
of Chief Executive Officer pursuant to Rules 13a-14(a) and
15d-14(a) promulgated under the Securities Exchange Act of 1934, as
amended, as adopted pursuant to Section 302(a) of the
Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
Certification
of Chief Financial Officer pursuant to Rules 13a-14(a) and
15d-14(a) promulgated under the Securities Exchange Act of 1934, as
amended, as adopted pursuant to Section 302(a) of the
Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
Certification
of Chief Executive Officer and Chief Financial Officer pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.*
|
|
|
|
|
101.INS
|
|
XBRL
Instance Document
|
|
|
|
101.SCH
|
|
XBRL
Taxonomy Extension Schema Document
|
|
|
|
101.CAL
|
|
XBRL
Taxonomy Extension Calculation Linkbase Document
|
|
|
|
101.DEF
|
|
XBRL
Taxonomy Extension Definition Linkbase Document
|
|
|
|
101.LAB
|
|
XBRL
Taxonomy Extension Label Linkbase Document
|
|
|
|
101.PRE
|
|
XBRL
Taxonomy Extension Presentation Linkbase Document
|
|
|
Aehr
Test Systems
|
|
|
|
Registrant)
|
|
|
|
|
|
Date:
October 12, 2018
|
By:
|
/s/ GAYN ERICKSON
|
|
|
|
Gayn
Erickson
|
|
|
|
President
and Chief Executive Officer
|
|
Date:
October 12, 2018
|
By:
|
/s/
KENNETH B. SPINK
|
|
|
|
Kenneth
B. Spink
|
|
|
|
Vice
President of Finance and Chief Financial
Officer
|
|
|
|
/s/
GAYN
ERICKSON
|
|
|
|
Gayn
Erickson
|
|
|
|
President and Chief
Executive Officer
|
|
|
/s/
KENNETH
B. SPINK
|
|
|
|
Kenneth B.
Spink
|
|
|
|
Vice President of
Finance and Chief Financial
Officer
|
|
|
/s/
GAYN
ERICKSON
|
|
|
|
Gayn
Erickson
|
|
|
|
President and Chief
Executive Officer
|
|
|
/s/
KENNETH
B. SPINK
|
|
|
|
Kenneth B.
Spink
|
|
|
|
Vice President of
Finance and
Chief Financial
Officer
|
Document and Entity Information - shares |
3 Months Ended | |
---|---|---|
Aug. 31, 2018 |
Sep. 28, 2018 |
|
Document And Entity Information | ||
Entity Registrant Name | AEHR TEST SYSTEMS | |
Entity Central Index Key | 0001040470 | |
Document Type | 10-Q | |
Document Period End Date | Aug. 31, 2018 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --05-31 | |
Is Entity's Reporting Status Current? | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Emerging Growth Company | false | |
Entity Small Business | true | |
Entity Common Stock, Shares Outstanding | 22,253,698 | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2019 |
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares |
Aug. 31, 2018 |
May 31, 2018 |
---|---|---|
Statement of Financial Position [Abstract] | ||
Common stock, par value | $ 0.01 | $ 0.01 |
Common stock, shares authorized (in thousands) | 75,000 | 75,000 |
Common stock, shares issued (in thousands) | 22,245 | 22,143 |
Common stock, shares outstanding (in thousands) | 22,245 | 22,143 |
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Aug. 31, 2018 |
Aug. 31, 2017 |
|
Income Statement [Abstract] | ||
Net sales | $ 4,740 | $ 6,970 |
Cost of sales | 3,187 | 4,052 |
Gross profit | 1,553 | 2,918 |
Operating expenses: | ||
Selling, general and administrative | 1,879 | 1,791 |
Research and development | 1,116 | 955 |
Total operating expenses | 2,995 | 2,746 |
(Loss) income from operations | (1,442) | 172 |
Interest expense, net | (78) | (107) |
Other income (expense), net | 9 | (60) |
(Loss) income before income tax (expense) benefit | (1,511) | 5 |
Income tax (expense) benefit | (4) | 5 |
Net (loss) income | (1,515) | 10 |
Less: Net income attributable to the noncontrolling interest | 0 | 0 |
Net (loss) income attributable to Aehr Test Systems common shareholders | $ (1,515) | $ 10 |
Net (loss) income per share basic | $ (0.07) | $ .00 |
Net (loss) income per share diluted | $ (0.07) | $ .00 |
Shares used in per share calculations: basic (in thousands) | 22,190 | 21,417 |
Shares used in per share calculations: diluted (in thousands) | 22,190 | 22,991 |
Condensed Consolidated Statements of Comprehensive (Loss) Income (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Aug. 31, 2018 |
Aug. 31, 2017 |
|
Statement of Comprehensive Income [Abstract] | ||
Net (loss) income | $ (1,515) | $ 10 |
Other comprehensive (loss) income, net of tax: Net change in cumulative translation adjustments | (15) | 59 |
Total comprehensive (loss) income | (1,530) | 69 |
Less: Comprehensive income attributable to the noncontrolling interest | 1 | 0 |
Comprehensive (loss) income, attributable to Aehr Test Systems common shareholders | $ (1,531) | $ 69 |
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | ||||
---|---|---|---|---|---|
Aug. 31, 2018 |
Aug. 31, 2017 |
||||
Cash flows from operating activities: | |||||
Net (loss) income | $ (1,515) | $ 10 | |||
Adjustments to reconcile net (loss) income to net cash used in operating activities: | |||||
Stock-based compensation expense | 256 | 216 | |||
Provision for doubtful accounts | 0 | 31 | |||
Depreciation and amortization | 111 | 89 | |||
Changes in operating assets and liabilities: | |||||
Accounts receivable | 563 | (1,260) | |||
Inventories | (536) | (2,044) | |||
Prepaid expenses and other assets | 4 | (1,089) | |||
Accounts payable | (398) | 651 | |||
Accrued expenses | (151) | (21) | |||
Customer deposits and deferred revenue | 609 | (440) | |||
Deferred rent | 82 | 0 | |||
Income taxes payable | 4 | (20) | |||
Net cash used in operating activities | (971) | (3,877) | |||
Cash flows from investing activities: | |||||
Purchases of property and equipment | (84) | (184) | |||
Net cash used in investing activities | (84) | (184) | |||
Cash flows from financing activities: | |||||
Proceeds from issuance of common stock under employee plans, net of taxes paid related to share settlement of equity awards | 109 | 234 | |||
Net cash provided by financing activities | 109 | 234 | |||
Effect of exchange rates on cash and cash equivalents | (38) | 17 | |||
Net decrease in cash and cash equivalents | (984) | (3,810) | |||
Cash and cash equivalents, beginning of period | 16,848 | [1] | 17,803 | ||
Cash and cash equivalents, end of period | 15,864 | 13,993 | |||
Supplemental disclosure of non-cash flow information: | |||||
Transfer of property and equipment to inventories | $ 0 | $ 372 | |||
|
1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCCOUNTING POLICIES |
3 Months Ended |
---|---|
Aug. 31, 2018 | |
Accounting Policies [Abstract] | |
1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCCOUNTING POLICIES | 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The accompanying financial information has been prepared by Aehr Test Systems, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission, or SEC. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (GAAP) have been condensed or omitted pursuant to such rules and regulations.
In the opinion of management, the unaudited condensed consolidated financial statements for the interim periods presented have been prepared on a basis consistent with the May 31, 2018 audited consolidated financial statements and reflect all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of the condensed consolidated financial position and results of operations as of and for such periods indicated. These unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended May 31, 2018. Results for the interim periods presented herein are not necessarily indicative of results which may be reported for any other interim period or for the entire fiscal year.
PRINCIPLES OF CONSOLIDATION. The condensed consolidated financial statements include the accounts of Aehr Test Systems and its subsidiaries (collectively, the "Company"). All significant intercompany balances have been eliminated in consolidation. For the Company’s majority owned subsidiary, Aehr Test Systems Japan K.K., the noncontrolling interest of the portion the Company does not own was reflected on the Condensed Consolidated Balance Sheets in Shareholders’ Equity and in the Condensed Consolidated Statements of Operations.
ACCOUNTING ESTIMATES. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used to account for sales and revenue allowances, the allowance for doubtful accounts, inventory valuations, income taxes, stock-based compensation expenses, and product warranties, among others. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances. Actual results could differ materially from those estimates.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES. The Company’s significant accounting policies are disclosed in the Company’s Annual Report on Form 10-K for the year ended May 31, 2018. There have been no significant changes in our significant accounting policies during the three months ended August 31, 2018 except for revenue recognition.
REVENUE RECOGNITION. Revenue consists primarily of the sale of the following products and services: systems, WaferPaks, DiePaks, upgrade services, spare parts, application support, service contracts and extended warranty contracts. Revenue is recognized upon transferring control of products and performing services, and the amounts recognized reflect the consideration we expect to be entitled to receive in exchange for these products and services. We sell our products and services directly to customers and through distributors.
A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. In contracts with multiple performance obligations, we identify each performance obligation and evaluate whether the performance obligation is distinct within the context of the contract at contract inception. A good or service that is not distinct is combined with other promised goods or services until the Company identifies a bundle of goods or services that is distinct.
Our products may be customized to our customers’ specifications, however, control of our product is typically transferred to the customer at the point in time the product is either shipped or delivered, depending on the terms of the arrangement, as the criteria for over time recognition is not met. In limited circumstances, substantive acceptance by the customer exists which results in the deferral of revenue until acceptance is formally received from the customer. Judgment may be required in determining if the acceptance clause is substantive.
Upgrade services are a distinct performance obligation apart from the systems and recognized in the period they are performed. Service contracts, which include repair and maintenance service contracts and extended warranty contracts, are also distinct performance obligations and recognized as our performance obligations are satisfied. This is typically the contractual service period, which ranges from one to three years. For these service contracts recognized over time, we use an input measure, days elapsed, to measure progress.
A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. In determining the transaction price, we evaluate whether the price is subject to refund or adjustment to determine the net consideration to which we expect to be entitled. We generally do not grant return privileges, except for defective products during the warranty period. Sales discounts that we may make available to these customers are considered to be a form of variable consideration, which is estimated in determining the contract’s transaction price to be allocated to the performance obligations. We have elected the practical expedient under Accounting Standards Codification (“ASC”) 606-10-32-18 to not assess whether a contract has a significant financing component as our standard payment terms are less than one year.
For contracts with multiple performance obligations, we allocate the contract’s transaction price to each performance obligation based on its relative standalone selling price. The stand-alone selling prices are determined based on the prices at which we separately sell these products. For items that are not sold separately, we estimate the stand-alone selling prices using our best estimate of selling price.
Transaction price allocated to the remaining performance obligations. On August 31, 2018, we had $685,000 of remaining performance obligations, which were comprised of deferred service contracts and extended warranty contracts not yet delivered. We expect to recognize approximately 34% of our remaining performance obligations as revenue in fiscal 2019, and an additional 66% in fiscal 2020 and thereafter. The foregoing excludes the value of other remaining performance obligations as they have original durations of one year or less, and also excludes information about variable consideration allocated entirely to a wholly unsatisfied performance obligation.
Contract Assets and Liabilities. The timing of revenue recognition may differ from the timing of invoicing to customers. Accounts receivable is recorded at the invoiced amount, net of an allowance for doubtful accounts. A receivable is recognized in the period we deliver goods or provide services or when our right to consideration is unconditional. The Company usually does not record contract assets because the Company has an unconditional right to payment upon satisfaction of the performance obligation, and therefore, a receivable is more commonly recorded than a contract asset.
Contract liabilities include payments received in advance of performance under a contract and are satisfied as the associated revenue is recognized. Contract liabilities are reported on the Condensed Consolidated Balance Sheets at the end of each reporting period as a component of deferred revenue. Contract liabilities as of August 31, 2018 and May 31, 2018 were $2,698,000 and $2,089,000, respectively. During the three months ended August 31, 2018, we recognized $602,000 of revenues that was included in contract liabilities as of May 31, 2018.
Costs to obtain or fulfill a contract. The Company generally expense sales commissions when incurred as a component of Selling, general and administrative expense as the amortization period is typically less than one year. Additionally, the majority of the Company’s cost of fulfillment as a manufacturer of products is classified as inventory and fixed assets, which are accounted for under the respective guidance for those asset types. Other costs of contract fulfillment are immaterial due to the nature of our products and their respective manufacturing process.
Amount collected from customers. Sales tax collected from customers is not included in net sales but rather recorded as a liability due to the respective taxing authorities.
RECENT ACCOUNTING PRONOUNCEMENTS
Accounting Standards Adopted
Revenue Recognition In May 2014, the FASB issued ASC Update No. 2014-09, Revenue from Contracts with Customers (Topic 606), which has been subsequently updated. The core principle of the standard is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. The new standard defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing GAAP, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price, and allocating the transaction price to each distinct performance obligation. The standard permits the use of either the retrospective or modified retrospective transition methods. It also requires expanded disclosures including the nature, amount, timing, and uncertainty of revenues and cash flows related to contracts with customers. Additionally, qualitative and quantitative disclosures are required about customer contracts, significant judgments and changes in judgments, and assets recognized from the costs to obtain or fulfill a contract.
We adopted Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers and all related amendments (collectively “ASC 606”), on June 1, 2018, the first day of fiscal 2019, using the modified retrospective method. We applied ASC 606 to all contracts not completed as of the date of adoption in order to determine any adjustment to the opening balance of retained earnings. Under the modified retrospective adoption method, the comparative financial information has not been restated and continues to be reported under the accounting standards in effect for those periods, ASC 605, "Revenue Recognition", which is also referred to herein as "legacy GAAP."
The adoption of ASC 606 did not have a material impact on our consolidated financial statements as of June 1, 2018. No adjustment was recorded to accumulated deficit as of the adoption date and reported revenue would not have been different under legacy GAAP. Additionally, we do not expect the adoption of the revenue standard to have a material impact to our net income on an ongoing basis.
Classification of Certain Cash Receipts and Cash Payments In August 2016, the FASB issued authoritative guidance related to the classification of certain cash receipts and cash payments on the statement of cash flows. The Company adopted this new standard in fiscal year 2019. The adoption of this guidance did not have a significant impact on the Company’s consolidated financial statements.
Intra-Entity Asset Transfers In October 2016, the FASB issued an accounting standard update that requires recognition of the income tax consequences of intra-entity transfers of assets (other than inventory) at the transaction date. The Company adopted this new standard in fiscal year 2019. The adoption of this guidance did not have a significant impact on the Company’s consolidated financial statements.
Restricted Cash In November 2016, the FASB issued authoritative guidance related to statements of cash flows. This guidance clarifies that amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of period total amounts shown on the statement of cash flows. The Company adopted this new standard in fiscal year 2019. The adoption of this guidance did not have a significant impact on the Company’s consolidated financial statements.
Income Taxes On December 22, 2017, the US government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”). The Tax Act makes broad and complex changes to the US tax code including but not limited to (1) reducing the US federal corporate tax rate from 34% to 21%; (2) requiring companies to pay a one-time transition tax on certain repatriated earnings of foreign subsidiaries; (3) generally eliminating US federal income taxes on dividends from foreign subsidiaries; (4) requiring a current inclusion in US federal income of certain earnings of controlled foreign corporations; (5) creating a new limitation on deductible interest expense; (6) changing rules related to the uses and limitations of net operating loss carryforwards created in tax years beginning after December 31, 2017, and (7) repeals the corporate alternative minimum tax regime, or AMT, effective December 31, 2017 and permits existing minimum tax credits to offset the regular tax liability for any tax year. Consequently, we have accounted for the reduction of $6.4 million of deferred tax assets with an offsetting adjustment to the valuation allowance for the fiscal year ended 2018, and recorded a benefit of $90,000 for our Federal refundable AMT credit.
On December 22, 2017, the SEC staff issued Staff Accounting Bulletin No. 118 (“SAB 118”) which provides guidance on accounting for the tax effects of the Tax act. SAB 118 provides a measurement period that should not extend beyond one year from the Tax Act enactment date for companies to complete the accounting under ASC 740, Income taxes. In accordance with SAB 118, a company must reflect the income tax effects of those aspects of the Tax Act for which the accounting under ASC 740 is complete. To the extent that a company’s accounting for certain income tax effects of the Tax Act is incomplete but it is able to determine a reasonable estimate, it must record a provisional estimate in the financial statements. There are also certain transitional impacts of the Tax Act. As part of the transition to the new territorial tax system, the Tax Act imposes a one-time repatriation tax on deemed repatriation of historical earnings of foreign subsidiaries. These transitional impacts have no impact to the company for the year fiscal year ended 2018. The one-time transition tax is based on post-1986 earnings and profits that were previously deferred from US income tax. While we have not yet finalized our calculation of the total post-1986 earnings and profits, for our foreign corporations or the impact of foreign tax credits, we have prepared a reasonable estimate and calculated the provision amount. The Company is evaluating the calculation of the transition tax. The accounting for this item is incomplete and may change as our interpretation of the provisions of the Act evolve, additional information becomes available or interpretive guidance is issued by the U.S. Treasury. The final determination will be completed no later than one year from the enactment date. Based on the current year and carryover losses and the valuation allowance the Company would not expect an impact to the financial statements as a result of the completion of the analysis.
Accounting Standards Not Yet Adopted
Financial Instruments In January 2016, the FASB issued an accounting standard update related to recognition and measurement of financial assets and financial liabilities. This standard changes accounting for equity investments, financial liabilities under the fair value option and the presentation and disclosure requirements for financial instruments. In addition, it clarifies guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on available-for-sale debt securities. This standard is effective for us in fiscal year 2020. Early adoption is permitted. The Company is currently evaluating the impact of this new guidance on its consolidated financial statements.
In June 2016, the FASB issued an accounting standard update that requires measurement and recognition of expected credit losses for financial assets held based on historical experience, current conditions, and reasonable and supportable forecasts that affect the collectibility of the reported amount. The accounting standard update will be effective for the Company beginning in the first quarter of fiscal 2021 on a modified retrospective basis, and early adoption in fiscal 2020 is permitted. The Company is currently evaluating the impact of this accounting standard update on its consolidated financial statements.
Leases In February 2016, the FASB issued authoritative guidance related to leases. This guidance requires management to present all leases greater than one year on the balance sheet as a liability to make payments and an asset as the right to use the underlying asset for the lease term. This new standard will be effective for us in fiscal year 2020, with early adoption permitted. The Company is currently evaluating the impact of adopting this new guidance on its consolidated financial statements.
|
2. EARNINGS PER SHARE |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2. EARNINGS PER SHARE | 2. EARNINGS PER SHARE
Basic earnings per share is determined using the weighted average number of common shares outstanding during the period. Diluted earnings per share is determined using the weighted average number of common shares and potential common shares (representing the dilutive effect of stock options, RSUs and ESPP shares) outstanding during the period using the treasury stock method.
The following table presents the computation of basic and diluted net (loss) income per share attributable to Aehr Test Systems common shareholders (in thousands, except per share data):
For the purpose of computing diluted earnings per share, the weighted average number of potential common shares does not include stock options with an exercise price greater than the average fair value of the Company’s common stock for the period, as the effect would be anti-dilutive. In the three months ended August 31, 2018, potential common shares have not been included in the calculation of diluted net loss per share as the effect would be anti-dilutive. As such, the numerator and the denominator used in computing both basic and diluted net loss per share for this period are the same. Stock options to purchase 3,189,000 shares of common stock, RSUs for 43,000 shares and ESPP rights to purchase 359,000 ESPP shares were outstanding as of August 31, 2018 but were not included in the computation of diluted net loss per share, because the inclusion of such shares would be anti-dilutive. Stock options to purchase 140,000 shares of common stock were outstanding as of August 31, 2017, but were not included in the computation of diluted net income per share, because the inclusion of such shares would be anti-dilutive. The 2,657,000 shares convertible under the convertible notes outstanding on August 31, 2018 and 2017 were not included in the computation of diluted net (loss) income per share, because the inclusion of such shares would be anti-dilutive.
|
3. CASH, CASH EQUIVALENTS AND INVESTMENTS |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash and Cash Equivalents [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3. CASH, CASH EQUIVALENTS AND INVESTMENTS | 3. CASH, CASH EQUIVALENTS AND INVESTMENTS
The following table summarizes the Company’s cash, cash equivalents and investments by security type at August 31, 2018 (in thousands):
Long-term investments are included in other assets on the accompanying condensed consolidated balance sheet at August 31, 2018.
The following table summarizes the Company’s cash, cash equivalents and investments by security type at May 31, 2018 (in thousands):
Long-term investments are included in other assets on the accompanying consolidated balance sheet at May 31. 2018.
Unrealized gains and temporary losses on investments classified as available-for-sale are included within accumulated other comprehensive income (“AOCI”), net of any related tax effect. Upon realization, those amounts are reclassified from AOCI to results of operations.
|
4. FAIR VALUE OF FINANCIAL INSTRUMENTS |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 31, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4. FAIR VALUE OF FINANCIAL INSTRUMENTS | 4. FAIR VALUE OF FINANCIAL INSTRUMENTS
The Company’s financial instruments are measured at fair value consistent with authoritative guidance. This authoritative guidance defines fair value, establishes a framework for using fair value to measure assets and liabilities, and disclosures required related to fair value measurements.
The guidance establishes a fair value hierarchy based on inputs to valuation techniques that are used to measure fair value that are either observable or unobservable. Observable inputs reflect assumptions market participants would use in pricing an asset or liability based on market data obtained from independent sources while unobservable inputs reflect a reporting entity’s pricing based upon their own market assumptions. The fair value hierarchy consists of the following three levels:
Level 1 - instrument valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets.
Level 2 - instrument valuations are obtained from readily-available pricing sources for comparable instruments.
Level 3 - instrument valuations are obtained without observable market values and require a high level of judgment to determine the fair value.
The following table summarizes the Company’s financial assets measured at fair value on a recurring basis as of August 31, 2018 (in thousands):
The following table summarizes the Company’s financial assets measured at fair value on a recurring basis as of May 31, 2018 (in thousands):
The U.S. Treasury Securities have maturities of three months.
There were no financial liabilities measured at fair value as of August 31, 2018 and May 31, 2018.
There were no transfers between Level 1 and Level 2 fair value measurements during the three months ended August 31, 2018.
The carrying amounts of financial instruments including cash, cash equivalents, receivables, accounts payable and certain other accrued liabilities, approximate fair value due to their short maturities. Based on the borrowing rates currently available to the Company for loans with similar terms, the carrying value of the debt approximates the fair value.
The Company has, at times, invested in debt and equity of private companies, and may do so again in the future, as part of its business strategy.
|
5. ACCOUNTS RECEIVABLE, NET |
3 Months Ended |
---|---|
Aug. 31, 2018 | |
Accounts Receivable, Net, Current [Abstract] | |
5. ACCOUNTS RECEIVABLE, NET | 5. ACCOUNTS RECEIVABLE, NET
Accounts receivable represent customer trade receivables and is presented net of allowance for doubtful accounts of $0 at August 31, 2018 and $4,000 at May 31, 2018. Accounts receivable are derived from the sale of products throughout the world to semiconductor manufacturers, semiconductor contract assemblers, electronics manufacturers and burn-in and test service companies. The Company’s allowance for doubtful accounts is based upon historical experience and review of trade receivables by aging category to identify specific customers with known disputes or collection issues. Uncollectible receivables are recorded as bad debt expense when all efforts to collect have been exhausted and recoveries are recognized when they are received.
|
6. INVENTORIES |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventory Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
6. INVENTORIES | 6. INVENTORIES
Inventories are comprised of the following (in thousands):
|
7. PRODUCT WARRANTIES |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Product Warranties Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7. PRODUCT WARRANTIES | 7. PRODUCT WARRANTIES
The Company provides for the estimated cost of product warranties at the time revenues are recognized on the products shipped. While the Company engages in extensive product quality programs and processes, including actively monitoring and evaluating the quality of its component suppliers, the Company’s warranty obligation is affected by product failure rates, material usage and service delivery costs incurred in correcting a product failure. Should actual product failure rates, material usage or service delivery costs differ from the Company’s estimates, revisions to the estimated warranty liability would be required.
The standard warranty period is one year for systems and ninety days for parts and service.
The following is a summary of changes in the Company's liability for product warranties during the three months ended August 31, 2018 and 2017 (in thousands):
The accrued warranty balance is included in accrued expenses on the accompanying condensed consolidated balance sheets.
|
8. CUSTOMER DEPOSITS AND DEFERRED REVENUE, SHORT-TERM |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 31, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||
Customer Deposits And Deferred Revenue Short-term | ||||||||||||||||||||||||||||||||||||||||||||||
8. CUSTOMER DEPOSITS AND DEFERRED REVENUE, SHORT-TERM | 8. CUSTOMER DEPOSITS AND DEFERRED REVENUE, SHORT-TERM
Customer deposits and deferred revenue, short-term (in thousands):
|
9. INCOME TAXES |
3 Months Ended |
---|---|
Aug. 31, 2018 | |
Income Tax Disclosure [Abstract] | |
9. INCOME TAXES | 9. INCOME TAXES
Income taxes have been provided using the liability method whereby deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and net operating loss and tax credit carryforwards measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse or the carryforwards are utilized. Valuation allowances are established when it is determined that it is more likely than not that such assets will not be realized.
Since fiscal 2009, a full valuation allowance was established against all deferred tax assets as management determined that it is more likely than not that certain deferred tax assets will not be realized.
The Company accounts for uncertain tax positions consistent with authoritative guidance. The guidance prescribes a “more likely than not” recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The Company does not expect any material change in its unrecognized tax benefits over the next twelve months. The Company recognizes interest and penalties related to unrecognized tax benefits as a component of income taxes.
On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”). On December 22, 2017, the SEC staff issued Staff Accounting Bulletin No. 118 (“SAB 118”), which provides guidance on accounting for the tax effects of the Tax Act. SAB 118 provides a measurement period that should not extend beyond one year from the Tax Act enactment date for companies to complete the accounting under ASC 740, Income taxes. In accordance with SAB 118, a company must reflect the income tax effects of those aspects of the Tax Act for which the accounting under ASC 740 is complete. To the extent that a company’s accounting for certain income tax effects of the Tax Act is incomplete but it is able to determine a reasonable estimate, it must record a provisional estimate in the financial statements.
As part of the transition to the new territorial tax system, the Tax Act imposes a one-time repatriation tax on deemed repatriation of historical earnings of foreign subsidiaries. The company is not subject to the transition tax. The one-time transition tax is based on post-1986 earnings and profits that were previously deferred from U.S. income tax. While the Company has not yet finalized its calculation of the total post-1986 earnings and profits for its foreign corporations or the impact of foreign tax credits, it has prepared a reasonable estimate and calculation of nil transition tax. The Company is continuing to evaluate the calculation and accounting of the transition tax, which may change as the Company's interpretation of the provisions of the Tax Act evolve, additional information becomes available or interpretive guidance is issued by the U.S. Treasury. The final determination will be completed no later than one year from the enactment date. Based on current year and carryover losses and valuation allowance, the Company does not expect an impact to its consolidated financial statements upon completion of the analysis.
The new law effective December 31, 2017 repeals the corporate alternative minimum tax, or AMT, regime and permits existing minimum tax credits to offset the regular tax liability for any tax year. Further, the credit is refundable for any tax year beginning after December 31, 2017 and before December 31, 2020 in an amount equal to 50% of the excess of the minimum tax credit over the allowable credit for the year against the regular tax liability. Any unused minimum tax credit carryforward is refundable in the following year. As result, the company recorded a benefit of $90,000 in the third quarter of fiscal 2018 for its Federal refundable AMT credit.
In addition, the reduction of the U.S. federal corporate tax rate reduces the corporate tax rate to 21%, effective January 1, 2018. Consequently, the Company has accounted for the reduction of $6.4 million of deferred tax assets with an offsetting adjustment to the valuation allowance.
Although the Company files U.S. federal, various state, and foreign tax returns, the Company’s only major tax jurisdictions are the United States, California, Germany and Japan. Tax years 1996 – 2017 remain subject to examination by the appropriate governmental agencies due to tax loss carryovers, research and development tax credits, or other tax attributes from those years.
|
10. LONG-TERM DEBT |
3 Months Ended |
---|---|
Aug. 31, 2018 | |
Long-term Debt, Unclassified [Abstract] | |
10. LONG-TERM DEBT | 10. LONG-TERM DEBT
On April 10, 2015, the Company entered into a Convertible Note Purchase and Credit Facility Agreement (the “Purchase Agreement”) with QVT Fund LP and Quintessence Fund L.P. (the “Purchasers”) providing for (a) the Company’s sale to the Purchasers of $4,110,000 in aggregate principal amount of 9.0% Convertible Secured Notes due 2017 (the “Convertible Notes”) and (b) a secured revolving loan facility (the “Credit Facility”) in an aggregate principal amount of up to $2,000,000. On August 22, 2016 the Purchase Agreement was amended to extend the maturity date of the Convertible Notes to April 10, 2019, decrease the conversion price from $2.65 per share to $2.30 per share, decrease the forced conversion price from $7.50 per share to $6.51 per share, and allow for additional equity awards.
The Convertible Notes bear interest at an annual rate of 9.0% and will mature on April 10, 2019 unless repurchased or converted prior to that date. Interest is payable quarterly on March 1, June 1, September 1 and December 1 of each year. Debt issuance costs of $356,000, which were accreted over the term of the original loan using the effective interest rate method, were offset against the loan balance.
The conversion price for the Convertible Notes is $2.30 per share and is subject to adjustment upon the occurrence of certain specified events. Holders may convert all or any part of the principal amount of their Convertible Notes in integrals of $10,000 at any time prior to the maturity date. Upon conversion, the Company will deliver shares of its common stock to the holder of Convertible Notes electing such conversion. The Company may not redeem the Convertible Notes prior to maturity.
The maximum amount of $2,000,000 drawn against the Credit Facility has been converted to Convertible Notes, and at August 31, 2018 there was no remaining balance available to be drawn on the Credit Facility.
The Company’s obligations under the Purchase Agreement are secured by substantially all of the assets of the Company.
|
11. STOCKHOLDERS’ EQUITY, COMPREHENSIVE INCOME AND STOCK-BASED COMPENSATION |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11. STOCKHOLDERS EQUITY, COMPREHENSIVE INCOME AND STOCK-BASED COMPENSATION | 11. STOCKHOLDERS’ EQUITY, COMPREHENSIVE INCOME AND STOCK-BASED COMPENSATION
ACCUMULATED OTHER COMPREHENSIVE INCOME
Changes in the components of AOCI, net of tax, were as follows (in thousands):
STOCK-BASED COMPENSATION
Stock-based compensation expense consists of expenses for stock options, restricted stock units, or RSUs, and employee stock purchase plan, or ESPP, purchase rights. Stock-based compensation expense for stock options and ESPP purchase rights is measured at each grant date, based on the fair value of the award using the Black-Scholes option valuation model, and is recognized as expense over the employee’s requisite service period. This model was developed for use in estimating the value of publicly traded options that have no vesting restrictions and are fully transferable. The Company’s employee stock options have characteristics significantly different from those of publicly traded options. For RSUs, stock-based compensation cost is based on the fair value of the Company’s common stock at the grant date. All of the Company’s stock-based compensation is accounted for as an equity instrument. See Note 10 in the Company’s Annual Report on Form 10-K for fiscal 2018 filed on August 28, 2018 for further information regarding the 2016 Equity Incentive Plan and the Amended and Restated 2006 ESPP.
The following table summarizes the stock-based compensation expense for the three months ended August 31, 2018 and 2017 (in thousands):
As of August 31, 2018 and 2017, there were no stock-based compensation expenses capitalized as part of inventory.
During the three months ended August 31, 2018 and 2017, the Company recorded stock-based compensation expenses related to stock options and RSUs of $173,000 and $201,000, respectively.
As of August 31, 2018, the total compensation expense related to unvested stock-based awards under the Company’s 2016 Equity Incentive Plan, but not yet recognized, was approximately $1,449,000, which is net of estimated forfeitures of $4,000. This expense will be amortized on a straight-line basis over a weighted average period of approximately 3.2 years.
During the three months ended August 31, 2018 and 2017, the Company recorded stock-based compensation expense related to the ESPP of $83,000 and $15,000, respectively.
As of August 31, 2018, the total compensation expense related to purchase rights under the ESPP but not yet recognized was approximately $223,000. This expense will be amortized on a straight-line basis over a weighted average period of approximately 1.1 years.
Valuation Assumptions
Valuation and Amortization Method. The Company estimates the fair value of stock options granted using the Black-Scholes option valuation model and a single option award approach. The fair value under the single option approach is amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period.
Expected Term. The Company’s expected term represents the period that the Company’s stock-based awards are expected to be outstanding and was determined based on historical experience, giving consideration to the contractual terms of the stock-based awards, vesting schedules and expectations of future employee behavior as evidenced by changes to the terms of its stock-based awards.
Volatility. Volatility is a measure of the amounts by which a financial variable such as stock price has fluctuated (historical volatility) or is expected to fluctuate (expected volatility) during a period. The Company uses the historical volatility for the past four or five years, which matches the expected term of most of the option grants, to estimate expected volatility. Volatility for each of the ESPP’s four time periods of six months, twelve months, eighteen months, and twenty-four months is calculated separately and included in the overall stock-based compensation expense recorded.
Risk-Free Interest Rate. The Company bases the risk-free interest rate used in the Black-Scholes option valuation model on the implied yield in effect at the time of option grant on U.S. Treasury zero-coupon issues with a remaining term equivalent to the expected term of the stock awards including the ESPP.
Fair Value. The fair value of the Company’s stock options granted to employees for the three months ended August 31, 2018 and 2017 were estimated using the following weighted average assumptions in the Black-Scholes option valuation model:
There were no ESPP purchase rights granted to employees for the three months ended August 31, 2018 and 2017. There were no ESPP shares issued during the three months ended August 31, 2018 and 2017. As of August 31, 2018, there were 145,000 ESPP shares available for issuance.
The following tables summarize the Company’s stock option and RSU transactions during three months ended August 31, 2018 (in thousands):
The following table summarizes the stock option transactions during the three months ended August 31, 2018 (in thousands, except per share data):
The options outstanding and exercisable at August 31, 2018 were in the following exercise price ranges (in thousands, except per share data):
The total intrinsic value of options exercised during the three months ended August 31, 2018 and 2017 was $139,000 and $476,000, respectively. The weighted average remaining contractual life of the options exercisable and expected to be exercisable at August 31, 2018 was 3.64 years.
During the three months ended August 31, 2018, there were no RSUs granted to employees. During the three months ended August 31, 2017, RSUs for 64,000 shares were granted to employees. The market value on the date of the grant of these RSUs was $3.93 per share. 2,000 RSUs became fully vested during the three months ended August 31, 2017, and 93,000 RSUs were unvested at August 31, 2017. During the three months ended August 31, 2018, 4,000 RSUs became fully vested. As of August 31, 2018, 43,000 RSUs remain unvested which have an intrinsic value of $108,000.
|
12. SEGMENT INFORMATION |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12. SEGMENT INFORMATION | 12. SEGMENT INFORMATION
The Company operates in one reportable segment: the design, manufacture and marketing of advanced test and burn-in products to the semiconductor manufacturing industry.
The following presents information about the Company’s operations in different geographic areas. Net sales are based upon ship-to location (in thousands).
The following table shows revenues by major product categories, similar to our reportable segment disclosure. Within each product category, contract terms, conditions and economic factors affecting the nature, amount, timing and uncertainty around revenue recognition and cash flow are substantially similar. With the exception of the amount of service revenues, our product category revenues are recognized at point in time when control transfers to customers. Our revenues by product category are as follows (in thousands):
There were no revenues through distributors for the three months ended August 31, 2018 and 2017.
The Company’s Japanese and German subsidiaries primarily comprise the foreign operations. Substantially all of the sales of the subsidiaries are made to unaffiliated Japanese or European customers. Net sales from outside the United States include those of Aehr Test Systems Japan K.K. and Aehr Test Systems GmbH.
Sales to the Company’s five largest customers accounted for approximately 78% and 99% of its net sales for the three months ended August 31, 2018 and 2017, respectively. Four customers accounted for approximately 21%, 18%, 17% and 14% of the Company’s net sales in the three months ended August 31, 2018. Two customers accounted for approximately 54% and 35% of the Company’s net sales in the three months ended August 31, 2017. No other customers represented more than 10% of the Company's net sales for either of the three months ended August 31, 2018 and 2017.
|
1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCCOUNTING POLICIES (Policies) |
3 Months Ended |
---|---|
Aug. 31, 2018 | |
Accounting Policies [Abstract] | |
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCCOUNTING POLICIES | BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The accompanying financial information has been prepared by Aehr Test Systems, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission, or SEC. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (GAAP) have been condensed or omitted pursuant to such rules and regulations.
In the opinion of management, the unaudited condensed consolidated financial statements for the interim periods presented have been prepared on a basis consistent with the May 31, 2018 audited consolidated financial statements and reflect all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of the condensed consolidated financial position and results of operations as of and for such periods indicated. These unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended May 31, 2018. Results for the interim periods presented herein are not necessarily indicative of results which may be reported for any other interim period or for the entire fiscal year.
|
PRINCIPLES OF CONSOLIDATION | PRINCIPLES OF CONSOLIDATION. The condensed consolidated financial statements include the accounts of Aehr Test Systems and its subsidiaries (collectively, the "Company"). All significant intercompany balances have been eliminated in consolidation. For the Company’s majority owned subsidiary, Aehr Test Systems Japan K.K., the noncontrolling interest of the portion the Company does not own was reflected on the Condensed Consolidated Balance Sheets in Shareholders’ Equity and in the Condensed Consolidated Statements of Operations.
|
ACCOUNTING ESTIMATES | ACCOUNTING ESTIMATES. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used to account for sales and revenue allowances, the allowance for doubtful accounts, inventory valuations, income taxes, stock-based compensation expenses, and product warranties, among others. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances. Actual results could differ materially from those estimates.
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES. The Company’s significant accounting policies are disclosed in the Company’s Annual Report on Form 10-K for the year ended May 31, 2018. There have been no significant changes in our significant accounting policies during the three months ended August 31, 2018 except for revenue recognition.
|
REVENUE RECOGNITION | REVENUE RECOGNITION. Revenue consists primarily of the sale of the following products and services: systems, WaferPaks, DiePaks, upgrade services, spare parts, application support, service contracts and extended warranty contracts. Revenue is recognized upon transferring control of products and performing services, and the amounts recognized reflect the consideration we expect to be entitled to receive in exchange for these products and services. We sell our products and services directly to customers and through distributors.
A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. In contracts with multiple performance obligations, we identify each performance obligation and evaluate whether the performance obligation is distinct within the context of the contract at contract inception. A good or service that is not distinct is combined with other promised goods or services until the Company identifies a bundle of goods or services that is distinct.
Our products may be customized to our customers’ specifications, however, control of our product is typically transferred to the customer at the point in time the product is either shipped or delivered, depending on the terms of the arrangement, as the criteria for over time recognition is not met. In limited circumstances, substantive acceptance by the customer exists which results in the deferral of revenue until acceptance is formally received from the customer. Judgment may be required in determining if the acceptance clause is substantive.
Upgrade services are a distinct performance obligation apart from the systems and recognized in the period they are performed. Service contracts, which include repair and maintenance service contracts and extended warranty contracts, are also distinct performance obligations and recognized as our performance obligations are satisfied. This is typically the contractual service period, which ranges from one to three years. For these service contracts recognized over time, we use an input measure, days elapsed, to measure progress.
A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. In determining the transaction price, we evaluate whether the price is subject to refund or adjustment to determine the net consideration to which we expect to be entitled. We generally do not grant return privileges, except for defective products during the warranty period. Sales discounts that we may make available to these customers are considered to be a form of variable consideration, which is estimated in determining the contract’s transaction price to be allocated to the performance obligations. We have elected the practical expedient under Accounting Standards Codification (“ASC”) 606-10-32-18 to not assess whether a contract has a significant financing component as our standard payment terms are less than one year.
For contracts with multiple performance obligations, we allocate the contract’s transaction price to each performance obligation based on its relative standalone selling price. The stand-alone selling prices are determined based on the prices at which we separately sell these products. For items that are not sold separately, we estimate the stand-alone selling prices using our best estimate of selling price.
Transaction price allocated to the remaining performance obligations. On August 31, 2018, we had $685,000 of remaining performance obligations, which were comprised of deferred service contracts and extended warranty contracts not yet delivered. We expect to recognize approximately 34% of our remaining performance obligations as revenue in fiscal 2019, and an additional 66% in fiscal 2020 and thereafter. The foregoing excludes the value of other remaining performance obligations as they have original durations of one year or less, and also excludes information about variable consideration allocated entirely to a wholly unsatisfied performance obligation.
Contract Assets and Liabilities. The timing of revenue recognition may differ from the timing of invoicing to customers. Accounts receivable is recorded at the invoiced amount, net of an allowance for doubtful accounts. A receivable is recognized in the period we deliver goods or provide services or when our right to consideration is unconditional. The Company usually does not record contract assets because the Company has an unconditional right to payment upon satisfaction of the performance obligation, and therefore, a receivable is more commonly recorded than a contract asset.
Contract liabilities include payments received in advance of performance under a contract and are satisfied as the associated revenue is recognized. Contract liabilities are reported on the Condensed Consolidated Balance Sheets at the end of each reporting period as a component of deferred revenue. Contract liabilities as of August 31, 2018 and May 31, 2018 were $2,698,000 and $2,089,000, respectively. During the three months ended August 31, 2018, we recognized $602,000 of revenues that was included in contract liabilities as of May 31, 2018.
Costs to obtain or fulfill a contract. The Company generally expense sales commissions when incurred as a component of Selling, general and administrative expense as the amortization period is typically less than one year. Additionally, the majority of the Company’s cost of fulfillment as a manufacturer of products is classified as inventory and fixed assets, which are accounted for under the respective guidance for those asset types. Other costs of contract fulfillment are immaterial due to the nature of our products and their respective manufacturing process.
Amount collected from customers. Sales tax collected from customers is not included in net sales but rather recorded as a liability due to the respective taxing authorities.
|
RECENT ACCOUNTING PRONOUNCEMENTS | RECENT ACCOUNTING PRONOUNCEMENTS
Accounting Standards Adopted
Revenue Recognition In May 2014, the FASB issued ASC Update No. 2014-09, Revenue from Contracts with Customers (Topic 606), which has been subsequently updated. The core principle of the standard is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. The new standard defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing GAAP, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price, and allocating the transaction price to each distinct performance obligation. The standard permits the use of either the retrospective or modified retrospective transition methods. It also requires expanded disclosures including the nature, amount, timing, and uncertainty of revenues and cash flows related to contracts with customers. Additionally, qualitative and quantitative disclosures are required about customer contracts, significant judgments and changes in judgments, and assets recognized from the costs to obtain or fulfill a contract.
We adopted Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers and all related amendments (collectively “ASC 606”), on June 1, 2018, the first day of fiscal 2019, using the modified retrospective method. We applied ASC 606 to all contracts not completed as of the date of adoption in order to determine any adjustment to the opening balance of retained earnings. Under the modified retrospective adoption method, the comparative financial information has not been restated and continues to be reported under the accounting standards in effect for those periods, ASC 605, "Revenue Recognition", which is also referred to herein as "legacy GAAP."
The adoption of ASC 606 did not have a material impact on our consolidated financial statements as of June 1, 2018. No adjustment was recorded to accumulated deficit as of the adoption date and reported revenue would not have been different under legacy GAAP. Additionally, we do not expect the adoption of the revenue standard to have a material impact to our net income on an ongoing basis.
Classification of Certain Cash Receipts and Cash Payments In August 2016, the FASB issued authoritative guidance related to the classification of certain cash receipts and cash payments on the statement of cash flows. The Company adopted this new standard in fiscal year 2019. The adoption of this guidance did not have a significant impact on the Company’s consolidated financial statements.
Intra-Entity Asset Transfers In October 2016, the FASB issued an accounting standard update that requires recognition of the income tax consequences of intra-entity transfers of assets (other than inventory) at the transaction date. The Company adopted this new standard in fiscal year 2019. The adoption of this guidance did not have a significant impact on the Company’s consolidated financial statements.
Restricted Cash In November 2016, the FASB issued authoritative guidance related to statements of cash flows. This guidance clarifies that amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of period total amounts shown on the statement of cash flows. The Company adopted this new standard in fiscal year 2019. The adoption of this guidance did not have a significant impact on the Company’s consolidated financial statements.
Income Taxes On December 22, 2017, the US government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”). The Tax Act makes broad and complex changes to the US tax code including but not limited to (1) reducing the US federal corporate tax rate from 34% to 21%; (2) requiring companies to pay a one-time transition tax on certain repatriated earnings of foreign subsidiaries; (3) generally eliminating US federal income taxes on dividends from foreign subsidiaries; (4) requiring a current inclusion in US federal income of certain earnings of controlled foreign corporations; (5) creating a new limitation on deductible interest expense; (6) changing rules related to the uses and limitations of net operating loss carryforwards created in tax years beginning after December 31, 2017, and (7) repeals the corporate alternative minimum tax regime, or AMT, effective December 31, 2017 and permits existing minimum tax credits to offset the regular tax liability for any tax year. Consequently, we have accounted for the reduction of $6.4 million of deferred tax assets with an offsetting adjustment to the valuation allowance for the fiscal year ended 2018, and recorded a benefit of $90,000 for our Federal refundable AMT credit.
On December 22, 2017, the SEC staff issued Staff Accounting Bulletin No. 118 (“SAB 118”) which provides guidance on accounting for the tax effects of the Tax act. SAB 118 provides a measurement period that should not extend beyond one year from the Tax Act enactment date for companies to complete the accounting under ASC 740, Income taxes. In accordance with SAB 118, a company must reflect the income tax effects of those aspects of the Tax Act for which the accounting under ASC 740 is complete. To the extent that a company’s accounting for certain income tax effects of the Tax Act is incomplete but it is able to determine a reasonable estimate, it must record a provisional estimate in the financial statements. There are also certain transitional impacts of the Tax Act. As part of the transition to the new territorial tax system, the Tax Act imposes a one-time repatriation tax on deemed repatriation of historical earnings of foreign subsidiaries. These transitional impacts have no impact to the company for the year fiscal year ended 2018. The one-time transition tax is based on post-1986 earnings and profits that were previously deferred from US income tax. While we have not yet finalized our calculation of the total post-1986 earnings and profits, for our foreign corporations or the impact of foreign tax credits, we have prepared a reasonable estimate and calculated the provision amount. The Company is evaluating the calculation of the transition tax. The accounting for this item is incomplete and may change as our interpretation of the provisions of the Act evolve, additional information becomes available or interpretive guidance is issued by the U.S. Treasury. The final determination will be completed no later than one year from the enactment date. Based on the current year and carryover losses and the valuation allowance the Company would not expect an impact to the financial statements as a result of the completion of the analysis.
Accounting Standards Not Yet Adopted
Financial Instruments In January 2016, the FASB issued an accounting standard update related to recognition and measurement of financial assets and financial liabilities. This standard changes accounting for equity investments, financial liabilities under the fair value option and the presentation and disclosure requirements for financial instruments. In addition, it clarifies guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on available-for-sale debt securities. This standard is effective for us in fiscal year 2020. Early adoption is permitted. The Company is currently evaluating the impact of this new guidance on its consolidated financial statements.
In June 2016, the FASB issued an accounting standard update that requires measurement and recognition of expected credit losses for financial assets held based on historical experience, current conditions, and reasonable and supportable forecasts that affect the collectibility of the reported amount. The accounting standard update will be effective for the Company beginning in the first quarter of fiscal 2021 on a modified retrospective basis, and early adoption in fiscal 2020 is permitted. The Company is currently evaluating the impact of this accounting standard update on its consolidated financial statements.
Leases In February 2016, the FASB issued authoritative guidance related to leases. This guidance requires management to present all leases greater than one year on the balance sheet as a liability to make payments and an asset as the right to use the underlying asset for the lease term. This new standard will be effective for us in fiscal year 2020, with early adoption permitted. The Company is currently evaluating the impact of adopting this new guidance on its consolidated financial statements.
|
2. EARNINGS PER SHARE (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings per share | The following table presents the computation of basic and diluted net (loss) income per share attributable to Aehr Test Systems common shareholders (in thousands, except per share data):
|
3. CASH, CASH EQUIVALENTS AND INVESTMENTS (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash and Cash Equivalents [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash, cash equivalents and investments by security type | The following table summarizes the Company’s cash, cash equivalents and investments by security type at August 31, 2018 (in thousands):
The following table summarizes the Company’s cash, cash equivalents and investments by security type at May 31, 2018 (in thousands):
|
4. FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 31, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair value by hierarchy | The following table summarizes the Company’s financial assets measured at fair value on a recurring basis as of August 31, 2018 (in thousands):
The following table summarizes the Company’s financial assets measured at fair value on a recurring basis as of May 31, 2018 (in thousands):
|
6. INVENTORIES (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventory Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventories | Inventories are comprised of the following (in thousands):
|
7. PRODUCT WARRANTIES (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Product Warranties Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liability for product warranties | The following is a summary of changes in the Company's liability for product warranties during the three months ended August 31, 2018 and 2017 (in thousands):
|
8. CUSTOMER DEPOSITS AND DEFERRED REVENUE, SHORT-TERM (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 31, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||
Customer Deposits And Deferred Revenue Short-term | ||||||||||||||||||||||||||||||||||||||||||||||
Customer deposits and deferred revenue | Customer deposits and deferred revenue, short-term (in thousands):
|
11. STOCKHOLDERS’ EQUITY, COMPREHENSIVE INCOME AND STOCK-BASED COMPENSATION (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 31, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Changes in the components of AOCI | Changes in the components of AOCI, net of tax, were as follows (in thousands):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensation costs related to the Company's stock-based compensation | The following table summarizes the stock-based compensation expense for the three months ended August 31, 2018 and 2017 (in thousands):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair value assumptions for option valuation model | The fair value of the Company’s stock options granted to employees for the three months ended August 31, 2018 and 2017 were estimated using the following weighted average assumptions in the Black-Scholes option valuation model:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock option and RSU transactions | The following tables summarize the Company’s stock option and RSU transactions during three months ended August 31, 2018 (in thousands):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock option transactions | The following table summarizes the stock option transactions during the three months ended August 31, 2018 (in thousands, except per share data):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Options outstanding | The options outstanding and exercisable at August 31, 2018 were in the following exercise price ranges (in thousands, except per share data):
|
12. SEGMENT INFORMATION (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 31, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Company's operations in different geographic areas | The following presents information about the Company’s operations in different geographic areas. Net sales are based upon ship-to location (in thousands).
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disaggregation of revenue | Our revenues by product category are as follows (in thousands):
|
1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCCOUNTING POLICIES (Details Narrative) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Aug. 31, 2018 |
May 31, 2018 |
|
Accounting Policies [Abstract] | ||
Remaining performance obligations | $ 685 | |
Contract liabilities | 2,698 | $ 2,089 |
Recognition of contract liabilities | $ 602 |
2. EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | |
---|---|---|
Aug. 31, 2018 |
Aug. 31, 2017 |
|
Earnings Per Share [Abstract] | ||
Numerator: Net (loss) income | $ (1,515) | $ 10 |
Denominator for basic net (loss) income per share: Weighted average shares outstanding (in thousands) | 22,190 | 21,417 |
Shares used in basic net (loss) income per share calculation (in thousands) | 22,190 | 21,417 |
Effect of dilutive securities (in thousands) | 0 | 1,574 |
Denominator for diluted net (loss) income per share (in thousands) | 22,190 | 22,991 |
Basic net (loss) income per share | $ (0.07) | $ .00 |
Diluted net (loss) income per share | $ (0.07) | $ .00 |
2. EARNINGS PER SHARE (Details Narrative) - shares |
3 Months Ended | |
---|---|---|
Aug. 31, 2018 |
Aug. 31, 2017 |
|
Employee Stock Purchase Plan | ||
Options not included in the computation of diluted net (loss) income per share (in thousands) | 359 | |
Convertible Notes | ||
Options not included in the computation of diluted net (loss) income per share (in thousands) | 2,657 | 2,657 |
Stock Options | ||
Options not included in the computation of diluted net (loss) income per share (in thousands) | 3,189 | 140 |
Restricted Stock Units | ||
Options not included in the computation of diluted net (loss) income per share (in thousands) | 43 |
3. CASH, CASH EQUIVALENTS AND INVESTMENTS (Details) - USD ($) $ in Thousands |
Aug. 31, 2018 |
May 31, 2018 |
Aug. 31, 2017 |
May 31, 2017 |
|||
---|---|---|---|---|---|---|---|
Cash, cost | $ 2,587 | $ 3,132 | |||||
Cash, estimated fair value | 2,587 | 3,132 | |||||
Cash equivalents, cost | 13,277 | 13,716 | |||||
Cash equivalents, estimated fair value | 13,277 | 13,716 | |||||
Cash and cash equivalents, cost | 15,864 | 16,848 | [1] | $ 13,993 | $ 17,803 | ||
Cash and cash equivalents, estimated fair value | 15,864 | 16,848 | |||||
Long-term investments, certificate of deposit, cost | 80 | 80 | |||||
Long-term investments, certificate of deposit, estimed fair value | 80 | 80 | |||||
Cash, cash equivalents, and investments, cost | 15,944 | 16,928 | |||||
Cash, cash equivalents, and investments, estimated fair value | 15,944 | 16,928 | |||||
Money Market Funds At Carrying Value | |||||||
Cash equivalents, cost | 13,277 | 7,733 | |||||
Cash equivalents, estimated fair value | 13,277 | 7,733 | |||||
U.S. Treasury securities | |||||||
Cash equivalents, cost | 0 | 5,983 | |||||
Cash equivalents, estimated fair value | $ 0 | $ 5,983 | |||||
|
4. FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - USD ($) $ in Thousands |
Aug. 31, 2018 |
May 31, 2018 |
---|---|---|
Money market funds | $ 13,277 | $ 7,733 |
U.S. Treasury securities | 0 | 5,983 |
Certificate of deposit | 80 | 80 |
Assets | 13,357 | 13,796 |
Level 1 | ||
Money market funds | 13,277 | 7,733 |
U.S. Treasury securities | 0 | 5,983 |
Certificate of deposit | 0 | 0 |
Assets | 13,277 | 13,716 |
Level 2 | ||
Money market funds | 0 | 0 |
U.S. Treasury securities | 0 | 0 |
Certificate of deposit | 80 | 80 |
Assets | 80 | 80 |
Level 3 | ||
Money market funds | 0 | 0 |
U.S. Treasury securities | 0 | 0 |
Certificate of deposit | 0 | 0 |
Assets | $ 0 | $ 0 |
4. FAIR VALUE OF FINANCIAL INSTRUMENTS (Details Narrative) - USD ($) $ in Thousands |
Aug. 31, 2018 |
May 31, 2018 |
---|---|---|
Fair Value Disclosures [Abstract] | ||
Financial liabilities at fair value | $ 0 | $ 0 |
Transfers between Level 1 and Level 2 fair value measurements | $ 0 | $ 0 |
5. ACCOUNTS RECEIVABLE, NET (Details Narrative) - USD ($) $ in Thousands |
Aug. 31, 2018 |
May 31, 2018 |
---|---|---|
Accounts Receivable, Net, Current [Abstract] | ||
Allowance for doubtful accounts customer trade receivables | $ 0 | $ 4 |
6. INVENTORIES (Details) - USD ($) $ in Thousands |
Aug. 31, 2018 |
May 31, 2018 |
|||
---|---|---|---|---|---|
Inventory, Net [Abstract] | |||||
Raw materials and sub-assemblies | $ 6,103 | $ 5,747 | |||
Work in process | 3,248 | 3,068 | |||
Finished goods | 234 | 234 | |||
Inventory | $ 9,585 | $ 9,049 | [1] | ||
|
7. PRODUCT WARRANTIES (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Aug. 31, 2018 |
Aug. 31, 2017 |
|
Movement in Standard Product Warranty Accrual [Roll Forward] | ||
Balance at the beginning of the period | $ 135 | $ 113 |
Accruals for warranties issued during the period | 75 | 94 |
Consumption of reserves | (50) | (88) |
Balance at the end of the period | $ 160 | $ 119 |
7. PRODUCT WARRANTIES (Details Narrative) |
3 Months Ended |
---|---|
Aug. 31, 2018 | |
Commitments and Contingencies Disclosure [Abstract] | |
Standard warranty period | The standard warranty period is one year for systems and ninety days for parts and service. |
8. CUSTOMER DEPOSITS AND DEFERRED REVENUE, SHORT-TERM (Details) - USD ($) $ in Thousands |
Aug. 31, 2018 |
May 31, 2018 |
---|---|---|
Customer Deposits And Deferred Revenue Short-term | ||
Customer deposits | $ 2,014 | $ 1,340 |
Deferred revenue | 325 | 290 |
Total | $ 2,339 | $ 1,630 |
9. INCOME TAXES (Details Narrative) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended |
---|---|---|
Aug. 31, 2018 |
May 31, 2018 |
|
Income Tax Disclosure [Abstract] | ||
Federal refundable AMT credit | $ 0 | $ 90 |
Reduction of deferred tax assets | $ 0 | $ (6,400) |
10. LONG-TERM DEBT (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | |
---|---|---|
Aug. 31, 2018 |
Apr. 10, 2015 |
|
Debt Disclosure [Abstract] | ||
Convertible debt, principal amount | $ 6,110 | $ 4,110 |
Convertible note, interest rate | 9.00% | |
Convertible note, maturity | Apr. 10, 2019 | |
Convertible note, interest payment | Interest is payable quarterly on March 1, June 1, September 1 and December 1 of each year. | |
Debt issuance costs | $ 356 | |
Conversion price for the Convertible Notes | $ 2.30 | |
Convertible Notes, Terms of Conversion Feature | <p style="margin: 0in; margin-bottom: 0pt"><font style="font: 8pt Times New Roman, Times, Serif"> The conversion price for the Convertible Notes is $2.30 per share and is subject to adjustment upon the occurrence of certain specified events. Holders may convert all or any part of the principal amount of their Convertible Notes in integrals of $10,000 at any time prior to the maturity date. Upon conversion, the Company will deliver shares of its common stock to the holder of Convertible Notes electing such conversion. The Company may not redeem the Convertible Notes prior to maturity.</font><p></p></p> | |
Line of credit, maximum borrowing capacity | $ 2,000 | |
Balance available to borrow under the line of credit | $ 0 |
11. STOCKHOLDERS’ EQUITY, COMPREHENSIVE INCOME AND STOCK-BASED COMPENSATION (Details) $ in Thousands |
3 Months Ended | |||
---|---|---|---|---|
Aug. 31, 2018
USD ($)
| ||||
Accumulated other comprehensive income, beginning | $ 2,292 | [1] | ||
Other comprehensive (loss) income before reclassifications | (16) | |||
Amounts reclassified out of AOCI | 0 | |||
Other comprehensive income (loss), net of tax | (16) | |||
Accumulated other comprehensive income, ending | 2,276 | |||
Cumulative Translation Adjustments [Member] | ||||
Accumulated other comprehensive income, beginning | 2,292 | |||
Other comprehensive (loss) income before reclassifications | (16) | |||
Amounts reclassified out of AOCI | 0 | |||
Other comprehensive income (loss), net of tax | (16) | |||
Accumulated other comprehensive income, ending | 2,276 | |||
Unrealized loss on Investments, Net | ||||
Accumulated other comprehensive income, beginning | 0 | |||
Other comprehensive (loss) income before reclassifications | 0 | |||
Amounts reclassified out of AOCI | 0 | |||
Other comprehensive income (loss), net of tax | 0 | |||
Accumulated other comprehensive income, ending | $ 0 | |||
|
11. STOCKHOLDERS’ EQUITY, COMPREHENSIVE INCOME AND STOCK-BASED COMPENSATION (Details 1) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Aug. 31, 2018 |
Aug. 31, 2017 |
|
Stock-based compensation in the form of employee stock options, RSUs and ESPP purchase rights, included in: | ||
Total stock-based compensation | $ 256 | $ 216 |
Cost of Sales | ||
Stock-based compensation in the form of employee stock options, RSUs and ESPP purchase rights, included in: | ||
Total stock-based compensation | 36 | 22 |
Selling, General and Administrative | ||
Stock-based compensation in the form of employee stock options, RSUs and ESPP purchase rights, included in: | ||
Total stock-based compensation | 148 | 150 |
Research and Development | ||
Stock-based compensation in the form of employee stock options, RSUs and ESPP purchase rights, included in: | ||
Total stock-based compensation | $ 72 | $ 44 |
11. STOCKHOLDERS’ EQUITY, COMPREHENSIVE INCOME AND STOCK-BASED COMPENSATION (Details 2) - Stock Options - $ / shares |
3 Months Ended | |
---|---|---|
Aug. 31, 2018 |
Aug. 31, 2017 |
|
Expected term (in years) | 5 years | 4 years |
Volatility | 74.00% | 78.00% |
Risk-free interest rate | 2.75% | 1.75% |
Weighted average grant date fair value | $ 1.48 | $ 2.27 |
11. STOCKHOLDERS’ EQUITY, COMPREHENSIVE INCOME AND STOCK-BASED COMPENSATION (Details 3) - Stock Option and RSU Transactions |
3 Months Ended |
---|---|
Aug. 31, 2018
shares
| |
Available Shares, Beginning (in thousands) | 1,812 |
Options granted (in thousands) | (441) |
Shares cancelled (in thousands) | 13 |
Shares expired (in thousands) | (11) |
Available Shares, Ending (in thousands) | 1,373 |
11. STOCKHOLDERS’ EQUITY, COMPREHENSIVE INCOME AND STOCK-BASED COMPENSATION (Details 4) - Outstanding Options Stock Option Transactions $ / shares in Units, $ in Thousands |
3 Months Ended |
---|---|
Aug. 31, 2018
USD ($)
$ / shares
shares
| |
Options Outstanding, Beginning (in thousands) | shares | 2,859 |
Options granted (in thousands) | shares | 441 |
Options cancelled (in thousands) | shares | (13) |
Options exercised (in thousand) | shares | (98) |
Options Outstanding, Ending (in thousands) | shares | 3,189 |
Weighted Average Exercise Price Outstanding, Beginning | $ / shares | $ 2.04 |
Weighted Average Exercise Price Granted | $ / shares | 2.40 |
Weighted Average Exercise Price Cancelled | $ / shares | 1.64 |
Weighted Average Exercise Price Exercised | $ / shares | 1.12 |
Weighted Average Exercise Price Outstanding, Ending | $ / shares | $ 2.12 |
Aggregate Intrinsic Value, beginning balance | $ | $ 1,987 |
Aggregate Intrinsic Value, ending balance | $ | $ 1,757 |
Options fully vested and expected to vest, ending (in thousands) | shares | 3,156 |
Weighted Average Exercise Price for Options fully vested and expected to vest, ending | $ / shares | $ 2.12 |
Aggregate Intrinsic Value for Options fully vested and expected to vest, ending | $ | $ 1,746 |
11. STOCKHOLDERS’ EQUITY, COMPREHENSIVE INCOME AND STOCK-BASED COMPENSATION (Details 5) $ / shares in Units, $ in Thousands |
3 Months Ended |
---|---|
Aug. 31, 2018
USD ($)
$ / shares
shares
| |
$0.59-$0.97 | |
Options Outstanding, Ending (in thousands) | shares | 259 |
Weighted Average Remaining Contractual Life (Years) Options Outstanding | 6 months 4 days |
Weighted Average Exercise Price Outstanding, Ending | $ / shares | $ .67 |
Options exercisable shares, ending (in thousands) | shares | 259 |
Weighted Average Remaining Contractual Life (Years) Options Exercisable | 6 months 4 days |
Weighted Average Exercise Price for Options exercisable, ending | $ / shares | $ .67 |
$1.09-$1.36 | |
Options Outstanding, Ending (in thousands) | shares | 507 |
Weighted Average Remaining Contractual Life (Years) Options Outstanding | 1 year 3 months 11 days |
Weighted Average Exercise Price Outstanding, Ending | $ / shares | $ 1.28 |
Options exercisable shares, ending (in thousands) | shares | 506 |
Weighted Average Remaining Contractual Life (Years) Options Exercisable | 1 year 3 months 11 days |
Weighted Average Exercise Price for Options exercisable, ending | $ / shares | $ 1.28 |
$1.68-$2.06 | |
Options Outstanding, Ending (in thousands) | shares | 466 |
Weighted Average Remaining Contractual Life (Years) Options Outstanding | 4 years 14 days |
Weighted Average Exercise Price Outstanding, Ending | $ / shares | $ 1.74 |
Options exercisable shares, ending (in thousands) | shares | 318 |
Weighted Average Remaining Contractual Life (Years) Options Exercisable | 3 years 7 months 20 days |
Weighted Average Exercise Price for Options exercisable, ending | $ / shares | $ 1.77 |
$2.10-$2.81 | |
Options Outstanding, Ending (in thousands) | shares | 1,695 |
Weighted Average Remaining Contractual Life (Years) Options Outstanding | 4 years 4 months 2 days |
Weighted Average Exercise Price Outstanding, Ending | $ / shares | $ 2.44 |
Options exercisable shares, ending (in thousands) | shares | 1,130 |
Weighted Average Remaining Contractual Life (Years) Options Exercisable | 3 years 3 months 4 days |
Weighted Average Exercise Price for Options exercisable, ending | $ / shares | $ 2.47 |
$3.46-$3.93 | |
Options Outstanding, Ending (in thousands) | shares | 262 |
Weighted Average Remaining Contractual Life (Years) Options Outstanding | 5 years 10 months 28 days |
Weighted Average Exercise Price Outstanding, Ending | $ / shares | $ 3.86 |
Options exercisable shares, ending (in thousands) | shares | 94 |
Weighted Average Remaining Contractual Life (Years) Options Exercisable | 5 years 11 months 16 days |
Weighted Average Exercise Price for Options exercisable, ending | $ / shares | $ 3.76 |
$0.59-$3.93 | |
Options Outstanding, Ending (in thousands) | shares | 3,189 |
Weighted Average Remaining Contractual Life (Years) Options Outstanding | 3 years 7 months 28 days |
Weighted Average Exercise Price Outstanding, Ending | $ / shares | $ 2.12 |
Options exercisable shares, ending (in thousands) | shares | 2,307 |
Weighted Average Remaining Contractual Life (Years) Options Exercisable | 2 years 8 months 19 days |
Weighted Average Exercise Price for Options exercisable, ending | $ / shares | $ 1.96 |
Aggregate Intrinsic Value for Options exercisable, ending | $ | $ 1,541 |
11. STOCKHOLDERS’ EQUITY, COMPREHENSIVE INCOME AND STOCK-BASED COMPENSATION (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | |
---|---|---|
Aug. 31, 2018 |
Aug. 31, 2017 |
|
Stock-based compensation costs capitalized as part of inventory | $ 0 | $ 0 |
Intrinsic value of options exercised | $ 139 | 476 |
Weighted average remaining contractual life of the options exercisable and expected to be exercisable | 3 years 7 months 20 days | |
Stock Option and RSU Transactions | ||
Stock-based compensation expense related to stock options and RSUs | $ 173 | $ 201 |
Restricted Stock Units granted (in thousands) | 0 | 64 |
Market value on the date of the grant | $ 3.93 | |
Restricted Stock Units vested (in thousands) | 4 | 2 |
Restricted Stock Units unvested (in thousands) | 43 | 93 |
Restricted Stock Units unvested intrinsic value | $ 108 | |
2016 Equity Incentive Plan | ||
Unrecognized stock-based compensation | 1,449 | |
Estimated forfeitures of unvested stock based awards, amount | $ 4 | |
Weighted average period for recognition of costs | 3 years 2 months 12 days | |
Employee Stock Purchase Plan | ||
Weighted average period for recognition of costs | 1 year 1 month 6 days | |
Stock-based compensation related to the ESPP | $ 83 | $ 15 |
Compensation cost related to purchase rights under the ESPP but not yet recognized | $ 223 | |
ESPP purchase right granted (in thousands) | 0 | 0 |
ESPP shares issued (in thousands) | 0 | 0 |
ESPP shares available for issuance (in thousands) | 145 |
12. SEGMENT INFORMATION (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Aug. 31, 2018 |
Aug. 31, 2017 |
|
Net sales | $ 4,740 | $ 6,970 |
Property and equipment, net | 1,174 | 1,140 |
US | ||
Net sales | 2,695 | 1,290 |
Property and equipment, net | 1,130 | 1,089 |
Asia | ||
Net sales | 1,734 | 5,660 |
Property and equipment, net | 39 | 39 |
Europe | ||
Net sales | 311 | 20 |
Property and equipment, net | $ 5 | $ 12 |
12. SEGMENT INFORMATION (Details 1) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Aug. 31, 2018 |
Aug. 31, 2017 |
|
Net sales | $ 4,740 | $ 6,970 |
Systems | ||
Net sales | 1,806 | 3,476 |
Contactors | ||
Net sales | 1,153 | 2,677 |
Services | ||
Net sales | 1,781 | 817 |
Products and services transferred at a point in time | ||
Net sales | 4,118 | 6,500 |
Services transferred over time | ||
Net sales | $ 622 | $ 470 |
12. SEGMENT INFORMATION (Details Narrative) |
3 Months Ended | |
---|---|---|
Aug. 31, 2018 |
Aug. 31, 2017 |
|
Five Largest Customers | ||
Customers accounted for 10% or more of total revenues | 78.00% | 99.00% |
Customer A | ||
Customers accounted for 10% or more of total revenues | 21.00% | 54.00% |
Customer B | ||
Customers accounted for 10% or more of total revenues | 18.00% | 35.00% |
Customer C | ||
Customers accounted for 10% or more of total revenues | 17.00% | |
Customer D | ||
Customers accounted for 10% or more of total revenues | 14.00% |
@QD,=[,KA^BT'[+CD1> $1]1*=BF1)#:N['
MX!2E9SB 5_I#'1#JJMJ 0U)&D8(%6/B5R&1GM- !%8WAC#=ZQ?O/T&>8T8 ]
M.APH B\Y,+E,]*>Y[^ *6&"$P<7O IJ5F*M_8G,'V#DY1[NFIFDJIR;GT@X<
MWIX>7_*ZA1TBJ4%C^A6MH)/'+;M,?FWN[G3-85;PM>%;S>\8VX;473OB^N
M/_RNPFXT=F__L?%%4';PZR[D%U!+ P04 " !LATQ-F5R<(Q & "<)P
M$P 'AL+W1H96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03
M ,)7-#8Y0@Q]L-A14/ASW>+;CF(V&-]WT@]C\C?-_4$L#!!0 ( &R'
M3$WAS!;CN $ -$# 9 >&PO=V]R:W-H965T
V +M<]T *'N1@TPPPT5V,S+M4* =?;'8HP R1?)\,D8KTHR%2:V@S)=$2!CF#[:)+IJ 0Z J7C)%I^TM#W=$&B8K18H6C\
M^*^,*L5?\>@H[P5-2->)M_@F+G5S&8X;6N=8WZNN'X]%Z7RD\32<:)#R/:P/
M()7C^EG2/ZG^;$2,4/A^:N+]LC2>N7S.FDM>M]%>.+]@?O>
ME,$96Q'OO'CKO9=BG_",70+1''.<8O@Z9HE@GGU)P;=2'/D_<+X-3S85)A&>
MO%.8;!.DFP1I)$C_6^)63/HA"5OU5(-IXC194N+0Q4E>>9>!O8N/R/Z&3]/^
M39A&=I:.T_V2FX
F@Q9O*F.U\&C:FKG.@B@C
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MGTIH'3V:&$BQ@668(B2T DF8ATF'0D0EZ>;!<.
MX%H, )ET6HP0:/E$YTG-XSE%.KUB/6B\::8Y/+G)&*S\#2: $)X*D9G05 6-
M7K.*R8M[^)5W%-?:=9V1=6@N&]=;T#]XUYF^4WDI:^4=A#9OJGOYSD)H9B()
M7DQ9%:89#@O.SMI.$S.774?H%EHT?;=#0\O-_P)02P,$% @ ;(=,3:.2
MDD>T @ Z@H !D !X;"]W;W)K
@'=DWFO[X_$K$N6JD<^!*#WX[GD^<
M*ZHU^D_Z:9?ZQ!XWC)Z466*]%OVQU6\4;X
H@[1F):"Z 1J :U+ )51)A\AG![>%91"&):RW()*YCF@@;V%!%)(_&@=7MV
MX;@4H06X/D N3\CG+0,Y-)\5O!,M^4J-ZILFRLG"AYV =)W%?8RR#^V;*:Y
M=T:#Y-XHN49*,"^)- (%( MP%/= ?OE6UE\U*S"S=_2UCRTLYLJI$/[".2$^
M66P10J@PSH"HDQS%4_H9;E86^!?'0T2